New hope for elderly cancer patients: triple therapy shows promise in advanced colorectal cancer
NCT ID NCT03451370
First seen Apr 28, 2026 · Last updated Apr 28, 2026
Summary
This study looks at how well a combination of three drugs (capecitabine, oxaliplatin, and bevacizumab) works as a first treatment for elderly patients (70 years or older) with metastatic colorectal cancer that cannot be removed by surgery. The goal is to see how long the cancer stays under control. The study involves 121 participants and is observational, meaning it follows real-world practice without assigning treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ELDERLY METASTATIC COLORECTAL CANCER PATIENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Istituto Oncologico Veneto IRCCS
Padua, 35128, Italy
Conditions
Explore the condition pages connected to this study.